IRINOTECAN HYDROCHLORIDE
Substance profile for UNII 042LAQ1IIS, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 60837Substance Identity#
- UNII
- 042LAQ1IIS
- Preferred term
- IRINOTECAN HYDROCHLORIDE
- Registry number
- 136572-09-3
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C33H38N4O6.ClH.3H2O
Structure render from PubChem CID 60837Chemical And Database Identifiers#
- InChIKey
- KLEAIHJJLUAXIQ-JDRGBKBRSA-N
- SMILES
- O.O.O.Cl.CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC5=C1C=C(OC(=O)N6CCC(CC6)N7CCCCC7)C=C5
- RxCUI
- 153329
- PubChem
- 60837
- NCIt
- C1381
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | CAMPTOSAR (IRINOTECAN HYDROCHLORIDE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 20 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 13 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.] | 12 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [ACTAVIS PHARMA, INC.] | 9 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 9 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | CAMPTOSAR (IRINOTECAN HYDROCHLORIDE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 7 | |
| Irinotecan Hydrochloride | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION [APP PHARMACEUTICALS, LLC] | 6 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 6 | |
| Irinotecan Hydrochloride | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [SANDOZ INC] | 5 | |
| irinotecan hydrochloride | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 4 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | ONIVYDE (IRINOTECAN HYDROCHLORIDE) INJECTION [MERRIMACK PHARMACEUTICALS] | 4 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION [CIPLA LIMITED] | 2 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE (IRINOTECAN) INJECTION [AREVA PHARMACEUTICALS,INC.] | 1 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION [SUN PHARMA GLOBAL FZE] | 1 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| irinotecan hydrochloride | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 1 | |
| IRINOTECAN HYDROCHLORIDE | ACTIVE INGREDIENT | 042LAQ1IIS | IRINOTECAN HYDROCHLORIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |